SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (5341)1/13/1998 9:19:00 PM
From: Robert K.  Read Replies (1) | Respond to of 17367
 
Xoma no longer has right to cd20 royalties, as I have been told. Also I hear cacaitos analysis is good job. Lastly meningiococcemia has accrued almost 140 and will keep on accruing probably thru april when dsmb will probably meet. We may see 160 to 190 by then and that might be significant. bob



To: aknahow who wrote (5341)1/14/1998 5:03:00 AM
From: Tharos  Respond to of 17367
 
George,
Glad to hear you read it. Hope it supports my position that information is a commodity and you have to pay for access to the best/timelyist (butchered the SP on that one, sorry) information. Compustat would prove that sentiment, even thousand $s/month just for basic service.

Short term look for a 8-12 day rally, sparked by INTC and fuelled by other (hopefully) good reports. Once the quarterly reports quit, the market will once again focus their microscope on Asia's anus and find some cocoa or whatever it was you were talking about.

Did try the street.com and did not like a couple of the articles. My facts and theirs were different (if you can imagine that!!!). Been looking into Elliot Wave a bit, still have a hard time counting and figuring out the "exceptions." Programmed an interesting trading system into my computer, based on 12 day rate of change and a 10 day exponential moving average of the 12 day ROC. Normal excessive readings for NYSE are +-3, lately the readings are +-10. Hold on to your seat, George, I think we are in for a ride this year.
J